FDA panel narrowly backs multi-cancer blood test despite doubts it works

🌐 Medical Xpress (IM) —
FDA panel narrowly backs multi-cancer blood test despite doubts it works

AI Summary

A blood test designed to detect over 50 types of cancer early received narrow support from an FDA advisory panel, despite concerns about its effectiveness. The test could represent a major advance in cancer detection if validated.

A blood test that aims to catch more than 50 types of cancer before symptoms appear narrowly won the backing of U.S. Food and Drug Administration (FDA) advisers Wednesday, even as several doubted it works.

Health cancer detection blood test FDA medical technology cancer types healthcare innovation

Read original source →